Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Is hyperpigmentation in Systemic Sclerosis a perivascular dermal tattoo?

Henrot P, Moisan F, Seneschal J, Taïeb A, Cario M, Truchetet ME.

J Invest Dermatol. 2020 Mar 28. pii: S0022-202X(20)31204-5. doi: 10.1016/j.jid.2020.03.937. [Epub ahead of print] No abstract available.

PMID:
32234458
2.

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014.

Scherlinger M, Mertz P, Sagez F, Meyer A, Felten R, Chatelus E, Javier RM, Sordet C, Martin T, Korganow AS, Guffroy A, Poindron V, Richez C, Truchetet ME, Blanco P, Schaeverbeke T, Sibilia J, Devillers H, Arnaud L.

Autoimmun Rev. 2020 Mar 28:102531. doi: 10.1016/j.autrev.2020.102531. [Epub ahead of print] Review.

PMID:
32234406
3.

Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis.

Ledoult E, Launay D, Béhal H, Mouthon L, Pugnet G, Lega JC, Agard C, Allanore Y, Jego P, Fauchais AL, Harlé JR, Berthier S, Aouba A, Mekinian A, Diot E, Truchetet ME, Boulon C, Duhamel A, Hachulla E, Sobanski V; French National Scleroderma Cohort Network.

Arthritis Res Ther. 2020 Feb 18;22(1):30. doi: 10.1186/s13075-020-2113-6.

4.

Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis.

Henrot P, Moisan F, Laurent P, Manicki P, Kaulanjan-Checkmodine P, Jolivel V, Rezvani HR, Leroy V, Picard F, Boulon C, Schaeverbeke T, Seneschal J, Lazaro E, Taïeb A, Truchetet ME, Cario M.

J Invest Dermatol. 2020 Jan 16. pii: S0022-202X(20)30016-6. doi: 10.1016/j.jid.2019.11.026. [Epub ahead of print]

PMID:
31954725
5.

Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy.

Kostine M, Truchetet ME, Schaeverbeke T.

Rheumatology (Oxford). 2019 Dec 1;58(Suppl 7):vii68-vii74. doi: 10.1093/rheumatology/kez295. Review.

6.

Practical management of patients on Janus kinase inhibitor (JAKi) therapy: Practical fact sheets drawn up by the Rheumatism and Inflammation Club (CRI), a group endorsed by the French Society for Rheumatology (SFR).

Richez C, Morel J, Cornec D, Daïen C, Goupille P, Lazaro E, Lequerré T, Nocturne G, de Lédinghen V, Le Goff B, Pourcher V, Prati C, Seror R, Tournadre A, Truchetet ME, Sibilia J, Pham T.

Joint Bone Spine. 2019 Oct;86 Suppl 1:eS2-eS103. doi: 10.1016/S1297-319X(19)30154-X. Epub 2019 Oct 31. No abstract available.

PMID:
31791545
7.

HIV protease inhibitors and autoimmunity: An odd, but promising idea.

Galli G, Poissonnier A, Guégan JP, Charrier M, Sisirak V, Lazaro E, Truchetet ME, Richez C, Legembre P, Blanco P.

Autoimmun Rev. 2019 Oct;18(10):102370. doi: 10.1016/j.autrev.2019.102370. Epub 2019 Aug 9. No abstract available.

PMID:
31404704
8.

IL-17A Dissociates Inflammation from Fibrogenesis in Systemic Sclerosis.

Dufour AM, Borowczyk-Michalowska J, Alvarez M, Truchetet ME, Modarressi A, Brembilla NC, Chizzolini C.

J Invest Dermatol. 2020 Jan;140(1):103-112.e8. doi: 10.1016/j.jid.2019.05.026. Epub 2019 Jul 3.

PMID:
31276679
9.

Correlation between capillaroscopic classifications and severity in systemic sclerosis: results from SCLEROCAP study at inclusion.

Boulon C, Aiouaz S, Blaise S, Mangin M, Decamps-Le Chevoir J, Senet P, Lazareth I, Baudot N, Tribout L, Imbert B, Lapebie FX, Lacroix P, Truchetet ME, Seneschal J, Solanilla A, Skopinski S, Lazaro E, Quéré I, Pistorius MA, Le Hello C, Perez P, Carpentier P, Constans J.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):63-68. Epub 2019 May 30.

10.

CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis.

Lande R, Lee EY, Palazzo R, Marinari B, Pietraforte I, Santos GS, Mattenberger Y, Spadaro F, Stefanantoni K, Iannace N, Dufour AM, Falchi M, Bianco M, Botti E, Bianchi L, Alvarez M, Riccieri V, Truchetet ME, C L Wong G, Chizzolini C, Frasca L.

Nat Commun. 2019 May 1;10(1):1731. doi: 10.1038/s41467-019-09683-z.

11.

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.

Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E, Castellví I, Airó P, Vettori S, De Langhe E, Hachulla E, Erler A, Ananieva L, Krusche M, López-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri V, Hsu VM, Pozzi MR, Ancuta C, Rosato E, Mihai C, Kuwana M, Saketkoo LA, Chizzolini C, Hesselstrand R, Ullman S, Yavuz S, Rednic S, Caimmi C, Bloch-Queyrat C, Allanore Y; for EUSTAR network.

Ann Rheum Dis. 2019 Jul;78(7):979-987. doi: 10.1136/annrheumdis-2018-214816. Epub 2019 Apr 9.

PMID:
30967395
12.

Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy.

Vercruysse F, Barnetche T, Lazaro E, Shipley E, Lifermann F, Balageas A, Delbrel X, Fautrel B, Richez C, Schaeverbeke T, Truchetet ME.

Arthritis Res Ther. 2019 Feb 12;21(1):53. doi: 10.1186/s13075-019-1838-6.

13.

Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study.

Scherlinger M, Carcaud C, Truchetet ME, Barnetche T, Duffau P, Couzi L, Seneschal J, Blanco P, Lazaro E, Richez C.

Ann Rheum Dis. 2019 Jul;78(7):1007-1010. doi: 10.1136/annrheumdis-2018-214833. Epub 2019 Jan 4. No abstract available.

PMID:
30610064
14.

OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.

Jacquemin C, Augusto JF, Scherlinger M, Gensous N, Forcade E, Douchet I, Levionnois E, Richez C, Lazaro E, Duffau P, Truchetet ME, Seneschal J, Couzi L, Pellegrin JL, Viallard JF, Schaeverbeke T, Pascual V, Contin-Bordes C, Blanco P.

JCI Insight. 2018 Dec 20;3(24). pii: 122167. doi: 10.1172/jci.insight.122167.

15.

CCN proteins as potential actionable targets in scleroderma.

Henrot P, Truchetet ME, Fisher G, Taïeb A, Cario M.

Exp Dermatol. 2019 Jan;28(1):11-18. doi: 10.1111/exd.13806. Epub 2018 Dec 11.

PMID:
30329180
16.

3D ultrashort echo time MRI of the lung using stack-of-spirals and spherical k-Space coverages: Evaluation in healthy volunteers and parenchymal diseases.

Dournes G, Yazbek J, Benhassen W, Benlala I, Blanchard E, Truchetet ME, Macey J, Berger P, Laurent F.

J Magn Reson Imaging. 2018 Dec;48(6):1489-1497. doi: 10.1002/jmri.26212. Epub 2018 Sep 11.

PMID:
30203889
17.

Association of skin hyperpigmentation disorders with digital ulcers in systemic sclerosis: Analysis of a cohort of 239 patients.

Leroy V, Henrot P, Barnetche T, Cario M, Darrigade AS, Manicki P, Doutre MS, Lazaro E, Constans J, Barcat D, Vernhes JP, Richez C, Taieb A, Truchetet ME, Seneschal J; Fédération Hospitalo-Universitaire–Aquitaine's Care and Research Organisation for Inflammatory and Immune-Mediated Diseases.

J Am Acad Dermatol. 2019 Feb;80(2):478-484. doi: 10.1016/j.jaad.2018.07.033. Epub 2018 Aug 7.

PMID:
30092330
18.

Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances.

Laurent P, Sisirak V, Lazaro E, Richez C, Duffau P, Blanco P, Truchetet ME, Contin-Bordes C.

Front Immunol. 2018 Jul 23;9:1702. doi: 10.3389/fimmu.2018.01702. eCollection 2018. Review.

19.

T Follicular Helper Cells in Autoimmune Disorders.

Gensous N, Charrier M, Duluc D, Contin-Bordes C, Truchetet ME, Lazaro E, Duffau P, Blanco P, Richez C.

Front Immunol. 2018 Jul 17;9:1637. doi: 10.3389/fimmu.2018.01637. eCollection 2018. Review.

20.

Reply.

Truchetet ME, Schaeverbeke T.

Arthritis Rheumatol. 2018 Dec;70(12):2097-2098. doi: 10.1002/art.40677. Epub 2018 Oct 27. No abstract available.

21.

Increased risk of mortality in systemic sclerosis-associated digital ulcers: a systematic review and meta-analysis.

Meunier P, Dequidt L, Barnetche T, Lazaro E, Duffau P, Richez C, Couzi L, Truchetet ME, Seneschal J; FHU ACRONIM.

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):405-409. doi: 10.1111/jdv.15114. Epub 2018 Jul 17.

PMID:
29888406
22.

Impact of systemic sclerosis oral manifestations on patients' health-related quality of life: A systematic review.

Smirani R, Truchetet ME, Poursac N, Naveau A, Schaeverbeke T, Devillard R.

J Oral Pathol Med. 2018 Oct;47(9):808-815. doi: 10.1111/jop.12739. Epub 2018 Jul 5.

PMID:
29855076
23.

Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study.

Loustau C, Rosine N, Forien M, Ottaviani S, Juge PA, Lioté F, Bardin T, Richette P, Dieudé P, Richez C, Bannwarth B, Schaeverbeke T, Ea HK, Truchetet ME.

Joint Bone Spine. 2018 Dec;85(6):755-760. doi: 10.1016/j.jbspin.2018.03.015. Epub 2018 Apr 11.

PMID:
29654950
24.

Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets.

Scherlinger M, Guillotin V, Truchetet ME, Contin-Bordes C, Sisirak V, Duffau P, Lazaro E, Richez C, Blanco P.

Autoimmun Rev. 2018 Jun;17(6):625-635. doi: 10.1016/j.autrev.2018.01.012. Epub 2018 Apr 7. Review.

PMID:
29635077
25.

Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: A systematic review and meta-analysis.

Guillotin V, Bouhet A, Barnetche T, Richez C, Truchetet ME, Seneschal J, Duffau P, Lazaro E; Fédération Hospitalo-Universitaire Acronim.

Joint Bone Spine. 2018 Dec;85(6):663-668. doi: 10.1016/j.jbspin.2018.03.006. Epub 2018 Apr 6.

PMID:
29631068
26.

Microbiota Composition May Predict Anti-Tnf Alpha Response in Spondyloarthritis Patients: an Exploratory Study.

Bazin T, Hooks KB, Barnetche T, Truchetet ME, Enaud R, Richez C, Dougados M, Hubert C, Barré A, Nikolski M, Schaeverbeke T.

Sci Rep. 2018 Apr 3;8(1):5446. doi: 10.1038/s41598-018-23571-4.

27.

Re-thinking our understanding of immunity: Robustness in the tissue reconstruction system.

Truchetet ME, Pradeu T.

Semin Immunol. 2018 Apr;36:45-55. doi: 10.1016/j.smim.2018.02.013. Epub 2018 Mar 15. Review.

28.

IgE in lupus pathogenesis: Friends or foes?

Augusto JF, Truchetet ME, Charles N, Blanco P, Richez C.

Autoimmun Rev. 2018 Apr;17(4):361-365. doi: 10.1016/j.autrev.2017.11.027. Epub 2018 Feb 7. Review.

PMID:
29425937
29.

Assessment of subclinical atherosclerosis in systemic lupus erythematosus: A systematic review and meta-analysis.

Henrot P, Foret J, Barnetche T, Lazaro E, Duffau P, Seneschal J, Schaeverbeke T, Truchetet ME, Richez C.

Joint Bone Spine. 2018 Mar;85(2):155-163. doi: 10.1016/j.jbspin.2017.12.009. Epub 2017 Dec 27.

PMID:
29288864
30.

Protective Microbiota: From Localized to Long-Reaching Co-Immunity.

Chiu L, Bazin T, Truchetet ME, Schaeverbeke T, Delhaes L, Pradeu T.

Front Immunol. 2017 Dec 7;8:1678. doi: 10.3389/fimmu.2017.01678. eCollection 2017. Review.

31.

Switching from originator infliximab to biosimilar CT-P13 in real-life: The weight of patient acceptance.

Scherlinger M, Germain V, Labadie C, Barnetche T, Truchetet ME, Bannwarth B, Mehsen-Cetre N, Richez C, Schaeverbeke T; FHU ACRONIM.

Joint Bone Spine. 2018 Oct;85(5):561-567. doi: 10.1016/j.jbspin.2017.10.003. Epub 2017 Nov 14.

PMID:
29154920
32.

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.

Kostine M, Rouxel L, Barnetche T, Veillon R, Martin F, Dutriaux C, Dousset L, Pham-Ledard A, Prey S, Beylot-Barry M, Daste A, Gross-Goupil M, Lallier J, Ravaud A, Forcade E, Bannwarth B, Truchetet ME, Richez C, Mehsen N, Schaeverbeke T; FHU ACRONIM.

Ann Rheum Dis. 2018 Mar;77(3):393-398. doi: 10.1136/annrheumdis-2017-212257. Epub 2017 Nov 16.

PMID:
29146737
33.

Prevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter Study.

John G, Avouac J, Piantoni S, Polito P, Fredi M, Cozzi F, Airò P, Truchetet ME, Franceschini F, Allanore Y, Chizzolini C.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1218-1227. doi: 10.1002/acr.23454. Epub 2018 Jun 19.

34.

Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review.

Gensous N, Marti A, Barnetche T, Blanco P, Lazaro E, Seneschal J, Truchetet ME, Duffau P, Richez C; FHU ACRONIM.

Arthritis Res Ther. 2017 Oct 24;19(1):238. doi: 10.1186/s13075-017-1442-6. Review.

35.

The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study.

John G, Allanore Y, Polito P, Piantoni S, Fredi M, Avouac J, Franceschini F, Truchetet ME, Cozzi F, Airo P, Chizzolini C.

Rheumatology (Oxford). 2017 Nov 1;56(11):1874-1883. doi: 10.1093/rheumatology/kex230.

PMID:
28977630
36.

Serum sickness-like disease after switching to biosimilar infliximab.

Scherlinger M, Schaeverbeke T, Truchetet ME; Fédération Hospitalo Universitaire ACRONIM.

Rheumatology (Oxford). 2017 Nov 1;56(11):2032-2034. doi: 10.1093/rheumatology/kex268. No abstract available.

PMID:
28977481
37.

Reproducibility of capillaroscopic classifications of systemic sclerosis: results from the SCLEROCAP study.

Boulon C, Devos S, Mangin M, Decamps-Le Chevoir J, Senet P, Lazareth I, Baudot N, Tribout L, Imbert B, Blaise S, Sintes P, Lapebie FX, Lacroix P, Truchetet ME, Seneschal J, Solanilla A, Skopinski S, Lazaro E, Quéré I, Pistorius MA, Le Hello C, Perez P, Carpentier P, Constans J.

Rheumatology (Oxford). 2017 Oct 1;56(10):1713-1720. doi: 10.1093/rheumatology/kex246.

PMID:
28957554
38.

Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.

Eyraud A, Scouppe L, Barnetche T, Forcade E, Lazaro E, Duffau P, Richez C, Seneschal J, Truchetet ME; FHU ACRONIM.

Br J Dermatol. 2018 Mar;178(3):650-658. doi: 10.1111/bjd.15993. Epub 2018 Feb 1.

PMID:
28906550
39.

Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome: Data From the French ESPOIR Cohort.

Truchetet ME, Dublanc S, Barnetche T, Vittecoq O, Mariette X, Richez C, Blanco P, Mahler M, Contin-Bordes C, Schaeverbeke T; Fédération Hospitalo-Universitaire ACRONIM.

Arthritis Rheumatol. 2017 Dec;69(12):2292-2302. doi: 10.1002/art.40237.

40.

Efficacy of baricitinib in the treatment of rheumatoid arthritis.

Richez C, Truchetet ME, Kostine M, Schaeverbeke T, Bannwarth B.

Expert Opin Pharmacother. 2017 Sep;18(13):1399-1407. doi: 10.1080/14656566.2017.1359256. Epub 2017 Jul 27. Review.

PMID:
28737053
41.

Respiratory infections associated with anti-TNFα agents.

Blanchard E, Truchetet ME, Machelart I, Séneschal J, Raherison-Semjen C.

Med Mal Infect. 2017 Oct;47(6):375-381. doi: 10.1016/j.medmal.2017.05.002. Epub 2017 Jun 9. Review.

PMID:
28602386
42.

Immune-Mediated Repair: A Matter of Plasticity.

Laurent P, Jolivel V, Manicki P, Chiu L, Contin-Bordes C, Truchetet ME, Pradeu T.

Front Immunol. 2017 Apr 24;8:454. doi: 10.3389/fimmu.2017.00454. eCollection 2017. Review.

43.

Are Murine Fibroblasts Responsible for Fibrosis Reversion? Comment on the Article by Luchetti et al.

Henrot P, Truchetet ME, Cario-Andre M.

Arthritis Rheumatol. 2017 Aug;69(8):1703. doi: 10.1002/art.40139. Epub 2017 Jun 14. No abstract available.

44.

Neutrophil-derived mitochondrial DNA promotes receptor activator of nuclear factor κB and its ligand signalling in rheumatoid arthritis.

Contis A, Mitrovic S, Lavie J, Douchet I, Lazaro E, Truchetet ME, Goizet C, Contin-Bordes C, Schaeverbeke T, Blanco P, Rossignol R, Faustin B, Richez C, Duffau P.

Rheumatology (Oxford). 2017 Jul 1;56(7):1200-1205. doi: 10.1093/rheumatology/kex041.

PMID:
28340056
45.

Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors.

Darrigade AS, Milpied B, Truchetet ME, Schaeverbeke T, Laharie D, Zerbib F, Beylot-Barry M, Jouary T, Taïeb A, Ezzedine K, Seneschal J.

Acta Derm Venereol. 2017 Jun 9;97(6):731-734. doi: 10.2340/00015555-2636.

46.

Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers.

Juge PA, Truchetet ME, Pillebout E, Ottaviani S, Vigneau C, Loustau C, Cornec D, Pascart T, Snanoudj R, Bailly F, Cornec-Le Gall E, Schaeverbeke T, Saraux A, Dieudé P, Flipo RM, Richette P, Lioté F, Bardin T, Chalès G, Ea HK.

Joint Bone Spine. 2017 Oct;84(5):595-598. doi: 10.1016/j.jbspin.2016.09.020. Epub 2016 Nov 4.

PMID:
27825577
47.

Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis.

Truchetet ME, Demoures B, Eduardo Guimaraes J, Bertrand A, Laurent P, Jolivel V, Douchet I, Jacquemin C, Khoryati L, Duffau P, Lazaro E, Richez C, Seneschal J, Doutre MS, Pellegrin JL, Constans J, Schaeverbeke T, Blanco P, Contin-Bordes C; Fédération Hospitalo-Universitaire ACRONIM.

Arthritis Rheumatol. 2016 Nov;68(11):2784-2794. doi: 10.1002/art.39817. Epub 2016 Oct 9.

48.

Biotherapies in systemic lupus erythematosus: New targets.

Lazaro E, Scherlinger M, Truchetet ME, Chiche L, Schaeverbeke T, Blanco P, Richez C.

Joint Bone Spine. 2017 May;84(3):267-274. doi: 10.1016/j.jbspin.2016.07.004. Epub 2016 Sep 21.

PMID:
27663753
49.

Pigmented skin patches without scleroderma as a predominant clinical symptom revealing systemic sclerosis.

Darrigade AS, Vedie AL, Gauthier C, Cario-André M, Taieb A, Truchetet ME, Constans J, Seneschal J.

Clin Exp Dermatol. 2016 Jun;41(4):379-82. doi: 10.1111/ced.12752. Epub 2015 Sep 3.

PMID:
27171356
50.

Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis.

Pugès M, Biscay P, Barnetche T, Truchetet MÉ, Richez C, Seneschal J, Gensous N, Lazaro E, Duffau P.

Rheumatology (Oxford). 2016 Sep;55(9):1664-72. doi: 10.1093/rheumatology/kew211. Epub 2016 May 9. Review.

PMID:
27160278

Supplemental Content

Loading ...
Support Center